News Articles

Colorado's Indigenous leaders want power in legalization of psychedelics - Axios Denver

Sep 01, 2023 – Colorado's embrace of psychedelics will hurt Indigenous tribes and culture, native advocates warn.

Exploring the LSD-Derivative With Potential for Treating Mood Disorders

Sep 01, 2023 – Classical psychedelics like lysergic acid diethylamide (LSD) are in early clinical trials for conditions such as depression, anxiety and cluster ...

Huadong enters licence deal for MC2 Therapeutics' Wynzora cream

Sep 01, 2023 – LOA and PTSR Model - (aspirin + ketamine) · GlobalData · View all. The licence rights are for regions comprising mainland China, Hong Kong, ...

NY Ketamine Infusions, Field Trip Health and Wellness Ltd., Ketamine Clinics Los Angeles

Sep 01, 2023 – A recent report entitled "Global "Ketamine Clinic" Market Trends and Insights" is now available on Orbisresearch.com. Worldwide Ketamine Clinic ...

Ketamine

Field Trip Health

The 1st biosimilar OK'd as an MS DMT should save patients money

Sep 01, 2023 – Tyruko, a biosimilar for Tysabri that was recently FDA-approved as an MS DMT, should save patients money, columnist Ed Tobias writes.

DMT

Otsuka makes psychedelics play, buying Mindset - Pharmaphorum

Sep 01, 2023 – Japanese pharma group Otsuka has signed an agreement to acquire Canada's Mindset Pharma, a specialist in psychedelic medicines for ...

Otsuka

Magic Mushroom Psychedelic Can Help Ease Major Depression, Study Finds - NDTV

Sep 01, 2023 – A single dose of psilocybin can lead to a "rapid, robust, and sustained reduction" in symptoms of severe depression when taken in conjunction with ...

One dose of psilocybin may have lasting effects on major depression, study finds

Aug 31, 2023 – The study adds to a growing body of evidence that psilocybin can help people with treatment-resistant major depression.

Single Psilocybin Dose Again Shows Major Depression Benefit | MedPage Today

Aug 31, 2023 – Just one dose of psilocybin significantly improved depression symptoms and functional disability in patients with major depressive disorder (MDD), ...

Psilocybin

Dose

Using psychedelics in mental health treatment 'not hippy movement', says expert

Aug 31, 2023 – ... as magic mushrooms and MDMA can help treat mental health conditions like post-traumatic stress disorder and obsessive compulsive disorder.

MDMA

Single-Dose Psilocybin Significantly Improves Major Depressive Disorder Symptoms Within 8 Days

Aug 31, 2023 – Psilocybin treatment was linked to significant and sustained reductions in depressive symptoms and functional disability in patients with major ...

Psilocybin

Within

Psilocybin for Major Depressive Disorder | JN Learning - AMA Ed Hub

Aug 31, 2023 – In a new study, psilocybin showed promise as a treatment for major depressive disorder (MDD). JAMA Associate Editor Donald C. Goff, MD, ...

Single-Dose Psilocybin Treatment Significantly Reduces Depressive Symptoms

Aug 31, 2023 – A single dose of psilocybin in combination with psychologic support may reduce depressive symptoms in individuals with major depressive disorder ...

Psilocybin

Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial

Aug 31, 2023 – This randomized clinical trial examines the timing of onset of action, durability of benefit, and safety profile of single-dose psilocybin in ...

Psilocybin

Ketamine Is Killing the Dancefloor - VICE

Aug 31, 2023 – “Ketamine is more of an isolating drug. And if you've got a crowd full of people doing this sort of wonky, dissociative drug, from a DJ's point of ...

VICE

MPs call for magic mushrooms and psychedelic drugs to be downgraded | The Independent

Aug 31, 2023 – <p>Psilocybin mushrooms, aka magic mushrooms</p> ... of evidence” that suggests psychedelics – and psilocybin in particular – may have therapeutic ...

Allow drug testing at festivals next summer, new report tells Home Office

Aug 31, 2023 – A stock picture of an MDMA pill (Picture: Wikimedia Commons). The Home Office has been strongly urged to establish on-site drug testing at music ...

MDMA

Readers respond: Psilocybin needs more oversight - oregonlive.com

Aug 31, 2023 – I am writing in full support of forensic psychiatrist Brian Holoyda's op-ed suggesting that Oregon's psilocybin programs need greater control and ...

Psilocybin

California could legalize the use of hallucinatory drugs like Peyote. Do you agree? | Opinion

Aug 30, 2023 – Decriminalizing psychedelics like peyote by passing SB 58 could help heal the fraught relationship between California and its indigenous tribes.

Pete Davidson 'taking ketamine to treat depression' after checking himself into rehab

Aug 30, 2023 – And his friends have since confirmed that he was using ketamine, administered via a nasal spray, to try and help his depression. The drug was approved ...

DMT Pens: A Journey into the Depths of Consciousness - Digital Overload

Aug 30, 2023 – Explore the captivating world of DMT pens and embark on a mind-altering journey of self-discovery. Discover potential side effects and ...

DMT

Journey

Psilocybin v. Escitalopram: Study Compares Effects on Depression - Psychedelic Spotlight

Aug 30, 2023 – How does psilocybin — a psychedelic that remains illegal in the vast majority of the United States —stack up against frequently prescribed SSRI ...

Psychedelic Spotlight

The Psychedelic Paradigm Shift: Revolutionary Treatment or a Slippery Slope for Mental Health?

Aug 30, 2023 – Psychedelics occupy a critical junction in the realm of mental health, presenting innovative pathways for treating a variety of mental disorders, ...

Psychedelics

Legal psychedelics that'll trip you out - GreenState

Aug 30, 2023 – Many common psychedelic drugs like magic mushrooms strains, LSD, ... Sure, droves of people have eaten psilocybin mushrooms or let LSD dissolve on ...

MDMA / LSD

Espinoza: What are 'magic mushrooms' and who are using them? - Sunstar

Aug 30, 2023 – “Psilocybin mushrooms, commonly known as magic mushrooms, are a polyphyletic informal group of fungi that contain psilocybin, which turns into ...

Psychedelic Drugs Market Analysis: Current and Future Trends |

Aug 30, 2023 – The Psychedelic Drugs Market had a valuation of USD 2.6 Billion in 2022 and is set to reach USD 7.1 Billion by 2032, with a growth rate of 10.9% ...

Colorado's first Psychedelic Cup celebrates mushroom home growers - The Denver Post

Aug 30, 2023 – The Psychedelic Cup, coming to Mile High Station in Denver on Nov. 2, aims to collect data about psilocybin-containing mushrooms, ...

Over One-Third of Under 50s Are Open to Psychedelic Trials for Mental Health Treatment

Aug 29, 2023 – Aside from psilocybin, those aged between 18-24 were most interested psychedelic trials with ketamine (27%) and MDMA (26%).

MDMA / DMT

Hallucinogen use hits record-high in adults, survey reveals | Live Science

Aug 28, 2023 – ... surveyed adults ages 19 to 30, 8% reported using hallucinogens like LSD, MDMA, mescaline, peyote, PCP, shrooms or psilocybin sometime in 2022.

Indigenous people in Colorado say they should be leading plant-based psychedelics movement

Aug 28, 2023 – They worry that the measure decriminalizing psychedelics will allow the ... including two in psychedelic mushrooms — psilocybin and psilocin — and ...

Researchers Announce Positive Results from Phase 2 At-Home Ketamine Trial

Aug 28, 2023 – The study authors noted that other ketamine-based treatments could increase heart rate and blood pressure, but KET01 has not shown those effects.

Ketamine

Psychedelic Drugs Market Share, Size and Forecast to 2030 - Digital Journal

Aug 28, 2023 – ... is categorized into Below types that held the largest Psychedelic Drugs market share In 2023. Psilocybin; LSD; MDMA; DMT; Ketamine; Others ...

Psilocybin

Investasi Properti Crowdfunding - How To Invest In Psilocybin Stocks

Aug 28, 2023 – Investasi Properti Crowdfunding - How To Invest In Psilocybin Stocks-Join Defi mining, sleep can also get profit time:2023-08-28 02:26:37 ...

Psilocybin

Small Pharma (CVE:DMT) Stock Price Up 15.4% - Defense World

Aug 27, 2023 – (CVE:DMT – Get Free Report) rose 15.4% on Friday . The company traded as high as C$0.08 and last traded at C$0.08. Approximately 727,000 shares were ...

A case for legalizing therapeutic psychedelics | Opinion - NJ.com

Aug 27, 2023 – Psychedelics are a class of psychoactive substances that can alter consciousness and lead to profound changes in perception, thoughts, emotions, and ...

Psychedelics

Dan Crenshaw Advocates For PTSD Psychedelic Therapy Funding - YouTube

Aug 27, 2023 – Before the Congressional Recess, Rep. Dan Crenshaw (R-TX) discussed the benefits of psychedelic therapy for veterans with PTSD during a House ...

InvestmentPitch Media Video Discusses MindBio Therapeutics' - GlobeNewswire

Aug 25, 2023 – This groundbreaking trial represents a global precedent and stands as the sole clinical trial authorized for the take-home usage of LSD.

We Need to Chill Out About Categorizing 'Medical' Versus 'Recreational' | High Times

Aug 25, 2023 – Culture. Ketamine Shows Promise in Treating Benzodiazepine Withdrawal · Health · Study. psilocybin. NHL's Kyle Quincey To Open Psilocybin Retreat.

Psilocybin / Ketamine

Sunstone Therapies in Collaboration with the University of - GlobeNewswire

Aug 25, 2023 – ... Observation of Therapeutic Connection in Psilocybin-Assisted Therapy ... at the effect of psilocybin therapy on patients with cancer and major ...

Ketamine Shows Promise in Treating Benzodiazepine Withdrawal - High Times

Aug 25, 2023 – Sub-anesthetic ketamine infusions, which are already used for treatment-resistant depression (TRD), may also help people through benzodiazepine ...

Psilocybin

The Biggest Psychedelic News Stories of the Week - August 21st

Aug 25, 2023 – Psilocybin capsules clear stability tests for Australian distribution, new research explores psychedelics' impact on neural synchronization and ...

Psilocybin

Qualified support for greater use of ketamine to treat depression | New Zealand Doctor

Aug 25, 2023 – There are plenty of examples of drugs used and misused in psychiatric medicine, Dr Tapsell says, and it's important that people don't treat ketamine ...

Incannex preparing psilocybin therapy FDA IND application - Yahoo Finance

Aug 24, 2023 – ... to gain key regulatory approval to begin clinical trials in the US for its psilocybin-assisted psychotherapy development program (Psi-GAD).

Incannex Seeks FDA Approval for Psilocybin-Assisted Psychotherapy Program

Aug 24, 2023 – The application to the FDA will detail the safety, effectiveness, quality, and other data about the firm's psilocybin treatment.

Incannex / Monash

Removing Barriers of Accessibility to Psychedelics with Brett Waters

Aug 24, 2023 – The conversation dives into Reason for Hope's mission to prevent deaths of despair by promoting accessible psychedelic medicine and assisted therapies ...

Psychedelics

Ketamine A Breakthrough in Mental - Health Healthy Mind Psychiatry - Santa Clarita Magazine

Aug 24, 2023 – Ketamine therapy is a relatively new and potentially life-changing treatment for tough-to-treat depression. Several scientific studies, including ...

Ketamine

Begins Dosing Mb22001 in Phase 2 Clinical Trial in World First Take-Home Microdosing ...

Aug 24, 2023 – The microdose of this psychedelic medicine is sub-hallucinogenic and is taken ... solutions for safe and effective at home use of psychedelics.

Elon Musk's Use Of Ketamine May Contribute To Erratic Behavior, Says Ronan Farrow

Aug 24, 2023 – The ongoing use of ketamine by Tesla chief Elon Musk may be causing his unpredictable behavior, suggests journalist Ronan Farrow, WION reported. In a ...

Ketamine

Expanding the conversation around psilocybin at Telluride Mushroom Festival | Aspen Public Radio

Aug 24, 2023 – Jo Young is a social worker based in Durango who specializes in psychedelic integration work. Young says the use of psychedelics "can push us into ...

Add-on esketamine beneficial to patients with fluctuating antidepressant response

Aug 24, 2023 – Already, a previous study has laid out evidence of ketamine acting on the same receptors as antidepressants. [Pharmacol Rev 2018;70:621-660].